QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:COGT

Cogent Biosciences - COGT Stock Forecast, Price & News

$12.15
-0.35 (-2.80%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.85
$12.60
50-Day Range
$10.87
$15.16
52-Week Range
$3.79
$18.07
Volume
910,741 shs
Average Volume
1.24 million shs
Market Capitalization
$556.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.33

Cogent Biosciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
50.9% Upside
$18.33 Price Target
Short Interest
Bearish
10.41% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.31) to ($2.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Medical Sector

847th out of 1,023 stocks

Pharmaceutical Preparations Industry

415th out of 501 stocks

COGT stock logo

About Cogent Biosciences (NASDAQ:COGT) Stock

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Receive COGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter.

COGT Stock News Headlines

Cogent Biosciences, Inc. (COGT)
COGT Cogent Biosciences, Inc.
Cogent Biosciences: What's Ahead
Reviewing Cogent Biosciences After Last Week's Data
Cogent Biosciences reports Q1 results
See More Headlines
Receive COGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter.

COGT Company Calendar

Last Earnings
11/10/2021
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/21/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:COGT
Fax
N/A
Employees
77
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.33
High Stock Price Forecast
$19.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+50.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-72,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.87 million
Book Value
$3.23 per share

Miscellaneous

Free Float
43,986,000
Market Cap
$556.70 million
Optionable
Not Optionable
Beta
1.67

Key Executives

  • Mr. Andrew R. Robbins M.B.A. (Age 46)
    Pres, CEO & Director
    Comp: $961.32k
  • Dr. John Edward Robinson Ph.D.
    Chief Scientific Officer
  • Dr. Jessica Sachs M.D. (Age 47)
    Chief Medical Officer
    Comp: $595.24k
  • Mr. John L. Green C.A.Mr. John L. Green C.A. (Age 42)
    CPA, CFO & Principal Accounting Officer
  • Mr. Brad Barnett
    Chief Technology Officer
  • Mr. Evan D. Kearns J.D. (Age 42)
    Chief Legal Officer & Corp. Sec.
  • Ms. Erin Schellhammer
    Chief People Officer
  • Ms. Sara Saltzman
    Sr. VP of Regulatory Affairs
  • Mr. Dana R. Martin Pharm.D.
    Sr. VP of Medical Affairs & Chief Patient Officer
  • Brad Fell
    VP & Head of Medicinal Chemistry













COGT Stock - Frequently Asked Questions

Should I buy or sell Cogent Biosciences stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cogent Biosciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" COGT shares.
View COGT analyst ratings
or view top-rated stocks.

What is Cogent Biosciences' stock price forecast for 2023?

2 Wall Street analysts have issued 1 year target prices for Cogent Biosciences' stock. Their COGT share price forecasts range from $18.00 to $19.00. On average, they expect the company's share price to reach $18.33 in the next year. This suggests a possible upside of 50.9% from the stock's current price.
View analysts price targets for COGT
or view top-rated stocks among Wall Street analysts.

How have COGT shares performed in 2022?

Cogent Biosciences' stock was trading at $8.58 on January 1st, 2022. Since then, COGT stock has increased by 41.6% and is now trading at $12.15.
View the best growth stocks for 2022 here
.

When is Cogent Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our COGT earnings forecast
.

How were Cogent Biosciences' earnings last quarter?

Cogent Biosciences, Inc. (NASDAQ:COGT) announced its earnings results on Wednesday, November, 10th. The technology company reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.07.

What other stocks do shareholders of Cogent Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cogent Biosciences investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Viveve Medical (VIVE), Red Violet (RDVT), Freeport-McMoRan (FCX), HP (HPQ), Nutanix (NTNX), OPKO Health (OPK), STMicroelectronics (STM) and Actinium Pharmaceuticals (ATNM).

What is Cogent Biosciences' stock symbol?

Cogent Biosciences trades on the NASDAQ under the ticker symbol "COGT."

Who are Cogent Biosciences' major shareholders?

Cogent Biosciences' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.03%), Commodore Capital LP (9.43%), RA Capital Management L.P. (8.76%), State Street Corp (7.44%), Perceptive Advisors LLC (7.00%) and Vanguard Group Inc. (6.95%). Insiders that own company stock include Fairmount Funds Management Llc and John L Green.
View institutional ownership trends
.

How do I buy shares of Cogent Biosciences?

Shares of COGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cogent Biosciences' stock price today?

One share of COGT stock can currently be purchased for approximately $12.15.

How much money does Cogent Biosciences make?

Cogent Biosciences (NASDAQ:COGT) has a market capitalization of $556.70 million and generates $7.87 million in revenue each year. The technology company earns $-72,270,000.00 in net income (profit) each year or ($2.50) on an earnings per share basis.

How can I contact Cogent Biosciences?

Cogent Biosciences' mailing address is 2650 NORTH MILITARY TRAIL SUITE 300, BOCA RATON FL, 33431. The official website for the company is www.cogint.com. The technology company can be reached via phone at (617) 945-5576 or via email at jkopin@cogint.com.

This page (NASDAQ:COGT) was last updated on 12/6/2022 by MarketBeat.com Staff